Dopamine-opioid interactions in the rat striatum: A modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction

Neuropharmacology

Volumn 39, Issue 3, 2000, Pages 372-381

  Unterwald, Ellen M ^a,b   Cuntapay, Marie ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adenylyl cyclase; cAMP; Dopamine receptor; G proteins; Opioid receptor; Striatum

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENYLATE CYCLASE; CYCLIC AMP; DELTA OPIATE RECEPTOR; DOPAMINE 1 RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); OPIATE RECEPTOR; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ENZYME INHIBITION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; ANIMALS; BENZAZEPINES; CORPUS STRIATUM; DOPAMINE AGONISTS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION;

EID: 0033966633     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00154-9     Document Type: Article

References (43)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends in Neuroscience. 12:1989;366-375.
2. Attali B., Saya D., Vogel Z. κ-Opioid agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord. Journal of Neurochemistry. 52:1989;360-369.
3. Azaryan A.V., Coughlin L.J., Clock B.J., Cox B.M. Effect of chronic cocaine treatment on μ- and δ-opioid receptor mRNA levels in dopaminergically innervated brain regions. Journal of Neurochemistry. 66:1996;443-448.
4. Brown B.L., Albano J.D.M., Ekins R.P., Sgherzi A.M., Tampion W. A simple and sensitive saturation assay method for measurement of adenosine 3',5'-cyclic monophosphate. Biochemistry Journal. 121:1971;561-562.
5. Chen J.F., Aloyo V.J., Weiss B. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience. 54:1993;669-680.
6. Childers S.R. Opiate receptor-coupled second messenger systems. Life Sciences. 48:1991;1991-2003.
7. Collier H.O.J., Roy A.C. Morphine-like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation in rat brain homogenates. Nature. 248:1974;24-27.
8. Fink J.S., Smith G.P. Mesolimbocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats. Brain Research. 199:1980;359-385.
9. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
10. Gilman A.G. G proteins and dual control of adenylate cyclase. Cell. 36:1984;577-579.
11. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends in Neuroscience. 13:1990;244-253.
12. Grofova I. The identification of striatal and pallidal neurons projecting to substantia nigra. An experimental study by means of retrograde axonal transport of horseradish peroxidase. Brain Research. 91:1975;286-291.
13. Hilf G., Gierschik P., Jakobs K.H. Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. European Journal of Biochemistry. 186:1989;725-731.
14. Itzhak Y. Differential regulation of brain opioid receptors following repeated cocaine administration to guinea pigs. Drug Alc. Dep. 33:1993;53-59.
15. Koski G., Klee W.A. Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. Proceedings of the National Academy of Science. 78:1981;4185-4189.
16. Laugwitz K.-L., Offermanns S., Spicher K., Schlutz G. μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron. 10:1993;233-242.
17. Le Moine C., Normand E., Guitteny A.F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proceedings of the National Academy of Sciences USA. 87:1990;230-234.
18. 35S]thio)triphosphate binding. Molecular Pharmacology. 44:1993;115-123.
19. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends in Neuroscience. 18:1995;22-29.
20. Namir N., Polastron J., Allouche S., Hasbi A., Jauzac P. The δ-opioid receptor in SK-N-BE human neuroblastoma cell line undergoes heterologous desensitization. Journal of Neurochemistry. 68:1997;1764-1772.
21. Nestler E.J., Terwilliger R.Z., Walker J.R., Sevarino K.A., Duman R.S. Chronic cocaine treatment decreases levels of the G protein subunits Gia and Goa in discrete regions of rat brain. Journal of Neurochemistry. 55:1990;1079-1082.
22. Noble F., Cox B.M. Differential desensitization of μ- and δ-opioid receptors in selected neural pathways following chronic morphine treatment. British Journal of Pharmacology. 117:1996;161-169.
23. Noble F., Cox B.M. The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment. Journal of Pharmacological Experimental Theory. 283:1997;557-565.
24. Pfeiffer F.R., Wilson J.W., Weinstock J., Kuo G.Y., Chambers P.A., Holden K.G., Hahn R.A., Wardell J.R., Tobia A.J., Setler P.E., Sarau H.M. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. Journal of Medicinal Chemistry. 25:1982;352-358.
25. Roberts D.C.S., Koob G.F. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacology and Biochemistry Behaviour. 17:1982;901-904.
26. Robertson G.S., Robertson H.A. D-1 and D-2 dopamine agonist synergism: separate sites of action? TIPS. 8:1987;295-299.
27. 35S]thio]-triphosphate binding. Proceedings of the National Academy of Sciences USA. 92:1995;242-7246.
28. 35S]GTPγS autoradiography in rat brain. Journal of Neuroscience. 16:1996;8057-8066.
29. 35S]GTPγS autoradiography in rat brain. Journal of Neuroscience. 16:1996;2684-2692.
30. Stoof J.C., Kebabian J.W. Opposing roles for D1 and D2 dopamine receptors in efflux of cyclic AMP from rat striatum. Nature. 294:1981;366-368.
31. Striplin C.D., Kalivas P.W. Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse. 14:1993;10-15.
32. Surmeier D.J., Song W.J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. Journal of Neuroscience. 16:1996;6579-6591.
33. 5-enkephalin. Journal of Neuroscience. 18:1998;1923-1933.
34. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Research. 548:1991;100-110.
35. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Molecular Pharmacology. 47:1995;848-854.
36. Tsuruta K., Frey E.A., Grewe C.W., Cote T.E., Eskay R.L., Kebabian J.W. Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor. Nature. 292:1981;463-465.
37. Unterwald E.M., Tempe L.A., Koob G.F., Zukin R.S. Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions. Brain Research. 505:1989;111-118.
38. Unterwald E.M., Cox B.M., Kreek M.J., Cote T.E., Izenwasser S.E. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse. 15:1993;33-38.
39. Unterwald E.M., Rubenfeld J.M., Kreek M.J. Repeated cocaine administration upregulates κ and μ, but not δ, opioid receptors. NeuroReport. 5:1994;1613-1616.
40. Waddington J.l., Daly S.A. Regulation of unconditioned motor behaviour by D1:D2 dopamine receptor interactions. Waddington J.L. Neuroscience and Psychopharmacology: D1:D2 Dopamine Receptor Interactions. 1993;51-78 Academic Press, San Diego.
41. Wamsley J.K., Gerlert D.R., Filloux F.M., Dawson T.M. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. Journal of Chemistry Neuroanatolgy. 2:1989;119-137.
42. White F.J., Hu X.T. Electorphysiological correlates of D1:D2 interactions. Waddington J.L. Neuroscience and Psychopharmacology: D1:D2 Dopamine Receptor Interactions. 1993;79-114 Academic Press, San Diego.
43. Wilson C.J., Groves P.M. Fine structure and synaptic connections of the common spiny neuron of the rat neuostriatum: a study employing intracellular injection of horseradish peroxidase. Journal of Comparative Neurology. 194:1980;599-615.